Air from beehives comforts patients in Turkey
FILE PHOTO: Hives owned by beekeeper Huseyin Ceylan, who runs a facility for therapy using air from beehives to aid people recover from their ailments, are seen by a olive tree, in Karaburun, located in Turkey's Aegean coastal province of Izmir, Turkey, May 22, 2025. REUTERS/Umit Bektas/File Photo
FILE PHOTO: Beekeeper Huseyin Ceylan, who runs a facility for therapy using air from beehives to aid people recover from their ailments poses in Karaburun, located in Turkey's Aegean coastal province of Izmir, Turkey, May 22, 2025. REUTERS/Umit Bektas/File Photo
FILE PHOTO: Beekeeper Huseyin Ceylan, who runs a facility for therapy using air from beehives to aid people recover from their ailments checks his hives in Karaburun, located in Turkey's Aegean coastal province of Izmir, Turkey, May 22, 2025. REUTERS/Umit Bektas/File Photo
FILE PHOTO: Senay Ilhan and Ulku Ozman breath in air from beehives through ventilators in hopes of recovering from ailments at a facility owned by beekeeper Huseyin Ceylan in Karaburun, located in Turkey's Aegean coastal province of Izmir, Turkey, May 22, 2025. REUTERS/Umit Bektas/File Photo
KARABURUN, Turkey - At his farm tucked away in an idyllic valley near the Aegean Sea, beekeeper Huseyin Ceylan helps people recover from ailments by having them inhale air from hives.
Ceylan says people come regularly in late spring to Karaburun, in Turkey's Aegean coastal province of Izmir, mainly to supplement conventional treatment with traditional "apitherapy," a term derived from the Greek for bees.
Guests tend to stay several days in cabins in lush greenery, inhaling air from beehives for up to three hours a day, which Ceylan says helps with issues from allergies to migraines.
The government does not officially recognise the therapy though it is practiced by many other beekeepers round Turkey as well as in other countries including Germany and Russia.
Ceylan, who comes from a family of beekeepers and studied agriculture, started his bee farm in Karaburun 30 years ago. He has lobbied for years for the sector to be accepted, conducting research and presenting findings to officials.
"We are not against what we call Western medicine. After all, it is also very important too," he said, adding that his method goes hand-in-hand with conventional treatment.
"I have been doing this for fifteen years, trying to bring this into medicine."
CHILDHOOD NOSTALGIA
Ulku Ozman, 69, decided to try the therapy method after a friend suggested it when several surgeries and frequent use of medicines weakened her immune system.
In her nearly week-long visit, Ozman and others enter a cabin where ventilators connected to beehives deliver air.
Each session lasts 45 minutes, with participants moving every 15 minutes to breathe from three different beehives, each with a different smell. Guests pay around 5,000 lira ($128) per day for the treatment plus accommodation and food.
Seated across from the beehives with ventilators on their faces, the guests take deep breaths.
Senay Ilham, 68, has breast cancer that metastasized to her spine but is in remission after receiving conventional treatment.
"This smell seems familiar. It's like it is (coming) from my childhood," she said, recalling being stung by bees while playing outside as children with beekeepers working nearby.
"(The beehive air) always brings me a breeze from these things. It relaxes me both psychologically and physically." REUTERS
Join ST's Telegram channel and get the latest breaking news delivered to you.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Straits Times
21 hours ago
- Straits Times
'Japanese First' party shakes up election with alarm over foreigners
FILE PHOTO: Sanseito Secretary General Sohei Kamiya speaks during a debate with leaders of other political parties at the Japan National Press Club in Tokyo, Japan, July 2, 2025. Tomohiro Ohsumi/Pool via REUTERS/File Photo TOKYO - An upstart party is gaining support ahead of elections in Japan by railing against a 'silent invasion' of immigrants, pushing the government to tackle fears about foreigners as it drags into the mainstream rhetoric once confined to the political fringe. Birthed on YouTube during the COVID-19 pandemic spreading conspiracy theories about vaccinations and a cabal of global elites, the party, Sanseito, is widening its appeal with a 'Japanese First' campaign ahead of Sunday's upper house vote. And while polls show it may only secure 10 to 15 of the 125 seats up for grabs, it is further eroding the support of Prime Minister Shigeru Ishiba's shaky minority government increasingly beholden to opposition parties as it clings to power. "In the past, anyone who brought up immigration would be attacked by the left. We are getting bashed too, but are also gaining support," Sohei Kamiya, the party's 47-year-old charismatic leader, told Reuters in an interview. "The LDP and Komeito can't stay silent if they want to keep their support," Kamiya added, referring to Ishiba's Liberal Democratic Party, which has ruled Japan for most of the past seven decades, and its junior coalition partner. Kamiya's message has grabbed voters frustrated with a weak economy and currency that has lured tourists in record numbers in recent years, further driving up prices that Japanese can ill-afford, political analysts say. The fast-ageing society has also seen foreign-born residents hit a record of about 3.8 million last year, although that is still just 3% of the total population, a tiny fraction compared to numbers in the United States and Europe. Top stories Swipe. Select. Stay informed. Singapore Acute psychiatry services to be expanded across all healthcare clusters: MOH Singapore July BTO launch to have over 4,600 balance flats, 2 BTO projects with under than 3-year wait Singapore Baby died after mum took abortion pills and gave birth in toilet; coroner records an open verdict Life S'pore travel agency Beyond Expeditions criticised for planning, safety issues Business Tycoon Robert Kuok's daughter Kuok Hui Kwong appointed CEO of Shangri-La Asia Singapore Jail for drunk man who shoved stranger into Singapore River, causing him to drown Singapore 'Kpods broke our marriage, shattered our children': Woman on husband's vape addiction Singapore Asia-Pacific will need over 230k new pilots, 250k aircraft maintenance technicians by 2042: ICAO chief Kamiya, a former supermarket manager and English teacher, says he has drawn inspiration from U.S. President Donald Trump's "bold political style". It remains to be seen whether he can follow the path of other far-right parties with which he has drawn comparisons, such as Germany's AFD and Reform UK. Yet the ingredients are there, said Jeffrey Hall, a lecturer at Tokyo's Kanda university who has studied Japan's right-wing politics, pointing to their online following, appeal among young men and warnings about immigration eroding indigenous cultures. "Anti-foreign sentiment that was considered maybe taboo to talk about so openly is now out of the box," he added. With immigration emerging as a top election issue, Ishiba this week unveiled a new government taskforce to fight "crimes and disorderly conduct" by foreign nationals and his party has promised to pursue "zero illegal foreigners". Polls show Ishiba's ruling coalition is likely to lose its majority in the upper house vote, in a repeat of elections last year in the more powerful lower house. While he is expected to limp on, his government may have to broaden its coalition or strike deals with other parties on policy matters, analysts say. 'HOT-BLOODED' Kamiya, who won the party's first seat in 2022 after having gained notoriety for appearing to call for Japan's emperor to take concubines, has tried to tone down some controversial ideas formerly embraced by the party. His election manifesto, for example, includes plans to cut taxes and increase child benefits, policies promoted by a raft of opposition parties that led investors to fret about Japan's fiscal health and massive debt pile. While Sanseito is the latest in a string of small far-right parties that have struggled for a foothold in Japan's staid politics, its online support suggests it may have staying power. Its YouTube channel has 400,000 followers, more than any other party on the platform and three times that of the LDP, according to There are still hurdles. Like right-wing parties in the U.S. and Europe, Sanseito support skews heavily toward men in their twenties and thirties. Kamiya is trying to widen its appeal by fielding several female candidates such as the single-named singer Saya seen as likely to clinch a seat in Tokyo. Earlier in the campaign, Kamiya faced a backlash for branding gender equality policies a mistake, as they encourage women to work and keep them from having children. "Maybe because I am hot-blooded, that resonates more with men," Kamiya replied to a question on the party's greater appeal to men. REUTERS
Straits Times
2 days ago
- Straits Times
Researchers get $25m grant to screen, treat lung cancer in Asian patients
A team of clinicians and scientists from the National Cancer Centre Singapore have been awarded a $25 million grant. SINGAPORE - Researchers here have received a $25 million grant to work on tackling lung cancer in Asian patients across all stages – from risk prediction and early detection of those who are at risk, to personalised treatments of patients at more advanced stages of the illness. They want to gain a deeper understanding of why the disease – the deadliest cancer globally and one that kills three people each day in Singapore – behaves differently in Asian patients. Unlike in Western countries where lung cancer is mainly linked to smoking, nearly half of Singapore's lung cancer patients have never smoked. Many have non-small cell lung cancer, a type of the cancer that is often driven by mutations in a gene known as the EGFR. While the advent of targeted therapies in the past two decades have improved survival rates , most patients develop drug resistance within nine to 15 months, causing relapse. Even early-stage patients face relapse risks after surgery. The question is why. The $25 million grant comes from the Ministry of Health's National Medical Research Council. It establishes the project called Clarion, which stands for Conquering Lung Cancer Across All Stages With Research And Innovation. Clarion will build on more than a decade of research undertaken by a multidisciplinary team led by the National Cancer Centre Singapore (NCCS). The team also includes researchers from A*Star and the National University Cancer Institute, Singapore. At a media briefing at NCCS on July 15, Associate Professor Daniel Tan, a senior consultant in NCCS' Division of Medical Oncology, said lung cancer is a major challenge because some 60 per cent of cases are picked up in the late stages of the disease . Top stories Swipe. Select. Stay informed. Business MAS records net profit of $19.7 billion, fuelled by investment gains Business Singapore financial sector growth doubles in 2024, assets managed cross $6 trillion in a first: MAS Singapore $3b money laundering case: MinLaw acts against 4 law firms and 1 lawyer over seized properties Singapore Man charged with attempted murder of woman at Kallang Wave Mall Singapore Ex-cleaner jailed over safety lapses linked to guard's death near 1-Altitude rooftop bar Singapore SJI International resumes overseas trips amid ongoing probe into student's death in Maldives in 2024 Singapore Sengkang-Punggol LRT gets 15.8 per cent capacity boost with new trains Singapore 'Nobody deserves to be alone': Why Mummy and Acha have fostered over 20 children in the past 22 years Until now, it is not yet clear which group of people is at higher risk of having lung cancer, apart from those who have a family history. Studies elsewhere have also shown that pollution can be one of the non-smoking-related triggers of lung cancer, he said. The researchers want to find out who is at risk of the cancer in order to identify the right groups for screening, as well as find out which groups will progress to having more severe disease, and which ones will not, said Associate Professor Tam Wai Leong, deputy executive director of A*Star Genomic Institute of Singapore. Around two years ago, the national lung cancer research group launched Solstice, Singapore's first local lung cancer screening study to screen family members of lung cancer patients using low-dose CT scans. The new grant will enable them to expand this study. A screening study done in Taiwan found that about 2 per cent of 12,000 non-smokers who were screened had lung cancer. The Taiwan findings suggested that a family history of lung cancer among first-degree relatives significantly increases the risk of lung cancer. While the results of Singapore's screening programme are not ready, the lung cancer research team has achieved other milestones. These include discovering new biomarkers explaining drug resistance, and introducing comprehensive molecular profiling for lung cancer patients, allowing doctors to tailor treatments based on the genetic and molecular characteristics of their cancer. The group also set up Singapore's first multidisciplinary lung cancer clinic, where specialists collaborate to design personalised treatment plans for complex cases. The team's research serves up hope to Asians, particularly those who have never smoked but are at risk of lung cancer – like homemaker Tiffany Khor, 46 . She did not notice any symptoms of the disease until she started experiencing breathlessness and a persistent cough following the birth of her second child 10 years ago. An X-ray showed that her entire left lung was filled with fluid and that she had low oxygen levels. At that point, she was told that she had Stage 3B lung cancer had that spread to her diaphragm. Ms Tiffany Khor and her husband Josh Yong. She started experiencing breathlessness and a persistent cough following the birth of her second child 10 years ago. ST PHOTO: LIM YAOHUI Ms Khor stopped her chemotherapy treatment after only two sessions. 'I didn't know how long I would live, so I decided not to waste any more time undergoing treatment. I wanted to spend the rest of my time with my children,' she told the media at NCCS. After undergoing genomic and molecular testing, she was found to have ALK-positive non-small cell lung cancer, which could be treated using targeted therapy. However, she decided to seek alternative therapy, until early 2016 when she was too weak to decline treatment. At NCCS, scans showed that her cancer had spread to her brain, which meant her cancer had progressed to Stage 4. She went on targeted therapy and had home hospice care. In late 2023, when scans showed that her cancer spread to the lining of her brain and spinal cord, her husband Josh Yong was desperate for a solution. He researched different clinical trials and came across the drug NVL-655 which had just been cleared by the FDA for clinical trials in the United States in May 2024. From her oncologist, Mr Yong found out that Singapore was one of the sites in a multi-country trial for the oral chemotherapy drug and got her on the ALKOVE-1 trial in June 2024. Results have been very positive, with scans showing that the tumours in Ms Khor's spine and traces of the cancer from her brain lining have gone. Her cancer is now under control. Mr Yong said his wife has never been better mentally and physically since she started struggling with the cancer.
Straits Times
2 days ago
- Straits Times
Global childhood vaccination shows slight improvement but challenges remain
Find out what's new on ST website and app. A little girl reacts after receiving an oral vaccine during a vaccination drive for diphtheria, influenza, tetanus and pneumococcus in Lima, Peru November 7, 2020. REUTERS/Sebastian Castaneda/File Photo A million more children completed the critical three-dose vaccination against diseases like diphtheria, tetanus and whooping cough in 2024 compared to the previous year, according to new data released by the World Health Organization. Despite the progress, drastic changes in funding, growing global conflicts, and rising vaccine misinformation threaten to further stall or even reverse progress which poses a threat. "We've hit this very stubborn glass ceiling, and breaking through that glass to protect more children against vaccine-preventable diseases is becoming more difficult," WHO's director of the Department of Immunization, Vaccines and Biologicals, Kate O'Brien, told reporters. In 2024, 89% of infants globally, about 115 million, received at least one dose of the DTP vaccine, and roughly 109 million completed all three doses of the staple shot that protects against diphtheria, tetanus and pertussis, also known as whooping cough, according to the new national immunization coverage data released on Tuesday by the WHO and UNICEF. But, nearly 20 million infants missed at least one dose of DTP-containing vaccine, which includes 14.3 million "zero-dose" children who never received a single dose of any vaccine. This is 4 million more than the target for the year needed to stay on track with Immunization Agenda 2030 goals, the report added. The world is currently off track for the goal, which has been to halve the number of zero-dose children and achieve at least 90% global immunization coverage. Top stories Swipe. Select. Stay informed. World Trump arms Ukraine and threatens sanctions on countries that buy Russian oil Multimedia From local to global: What made top news in Singapore over the last 180 years? Singapore Turning tragedy into advocacy: Woman finds new purpose after paralysis Singapore HSA intensifies crackdown on vapes; young suspected Kpod peddlers nabbed in Bishan, Yishun Opinion Sumiko at 61: When beauty fades, why do some accept it better than others? Singapore Man charged over distributing nearly 3 tonnes of vapes in one day in Bishan, Ubi Avenue 3 Singapore Man allegedly attacks woman with knife at Kallang Wave Mall, to be charged with attempted murder Singapore Ex-cop charged after he allegedly went on MHA portal, unlawfully shared info with man Data shows a quarter of the world's infants live in just 26 countries affected by fragility, conflict, or humanitarian crises, yet make up half of all unvaccinated children globally. In half of these countries the number of unvaccinated children has expanded rapidly from 3.6 million in 2019 to 5.4 million in 2024. "We're starting to see the emerging signs of slippage, and in other countries, stalling of vaccine coverage," said O'Brien. Despite the challenges, countries have been able to scale up vaccines for diseases such as HPV, meningitis, pneumococcal disease, polio, and rotavirus. In 2024, 31% of eligible adolescent girls globally received at least one dose of the HPV vaccine. While this is far from the 90% coverage target by 2030, it represents a substantial increase from the 17% coverage in 2019. Global coverage against measles also improved, but the overall coverage rate is far below the 95% needed in every community to prevent outbreaks. "The good news is that we have managed to reach more children with life-saving vaccines. But millions of children remain without protection against preventable diseases, and that should worry us all," said UNICEF Executive Director Catherine Russell. REUTERS
